Iradimed (IRMD) Other Accumulated Expenses (2013 - 2026)

Iradimed (IRMD) has 14 years of Other Accumulated Expenses data on file, last reported at $427000.0 in Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $427000.0, up 66.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $427000.0 (up 66.16% YoY), and the FY2025 annual result was $313000.0, down 32.83% from the prior year.
• Other Accumulated Expenses improved to $427000.0 in Q1 2026 per IRMD's latest filing, from $313000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $466000.0 in Q4 2024 and troughed at $103241.0 in Q4 2023.
• A 5-year average of $230134.1 and a median of $217496.0 in 2023 frame the typical range for Other Accumulated Expenses.
• On a YoY basis, Other Accumulated Expenses climbed as much as 351.37% in 2024 and fell as far as 45.38% in 2024.
• A 5-year view of Other Accumulated Expenses shows it stood at $121919.0 in 2022, then retreated by 15.32% to $103241.0 in 2023, then soared by 351.37% to $466000.0 in 2024, then plunged by 32.83% to $313000.0 in 2025, then jumped by 36.42% to $427000.0 in 2026.
• Business Quant data shows IRMD's Other Accumulated Expenses at $427000.0 in Q1 2026, $313000.0 in Q4 2025, and $296207.0 in Q3 2025.